These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8423163)

  • 21. The R-type pyocin of Pseudomonas aeruginosa C is a bacteriophage tail-like particle that contains single-stranded DNA.
    Lee FK; Dudas KC; Hanson JA; Nelson MB; LoVerde PT; Apicella MA
    Infect Immun; 1999 Feb; 67(2):717-25. PubMed ID: 9916082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189.
    Naz SA; Jabeen N; Sohail M; Rasool SA
    Braz J Microbiol; 2015; 46(4):1147-54. PubMed ID: 26691474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    Six A; Mosbahi K; Barge M; Kleanthous C; Evans T; Walker D
    J Antimicrob Chemother; 2021 Aug; 76(9):2317-2324. PubMed ID: 34142136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research in the stability of pyocin-types and subtypes in Pseudomonas aeruginosa].
    Vlajinac H
    Vojnosanit Pregl; 1978 Oct; 35(5):345-9. PubMed ID: 103322
    [No Abstract]   [Full Text] [Related]  

  • 26. Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.
    Hocquet D; Petitjean M; Rohmer L; Valot B; Kulasekara HD; Bedel E; Bertrand X; Plésiat P; Köhler T; Pantel A; Jacobs MA; Hoffman LR; Miller SI
    Environ Microbiol; 2016 Oct; 18(10):3482-3493. PubMed ID: 27119970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Single-Shot Synthesis of the 214 Amino Acid-Long N-Terminal Domain of Pyocin S2.
    Saebi A; Brown JS; Marando VM; Hartrampf N; Chumbler NM; Hanna S; Poskus M; Loas A; Kiessling LL; Hung DT; Pentelute BL
    ACS Chem Biol; 2023 Mar; 18(3):518-527. PubMed ID: 36821521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor.
    Denayer S; Matthijs S; Cornelis P
    J Bacteriol; 2007 Nov; 189(21):7663-8. PubMed ID: 17720787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of pyocin R1.
    Iijima M
    J Biochem; 1978 Feb; 83(2):395-402. PubMed ID: 416014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pyocin typization of Pseudomonas aeruginosa].
    Vlajinac H
    Srp Arh Celok Lek; 1974 Dec; 102(12):901-11. PubMed ID: 4219453
    [No Abstract]   [Full Text] [Related]  

  • 31. R pyocin tail fiber structure reveals a receptor-binding domain with a lectin fold.
    Salazar AJ; Sherekar M; Tsai J; Sacchettini JC
    PLoS One; 2019; 14(2):e0211432. PubMed ID: 30721244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. II. Physical characterization of pyocin R2 genes using R-prime plasmids constructed from R68.45.
    Shinomiya T; Shiga S; Kikuchi A; Kageyama M
    Mol Gen Genet; 1983; 189(3):382-9. PubMed ID: 6306394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological cost of pyocin production during the SOS response in Pseudomonas aeruginosa.
    Penterman J; Singh PK; Walker GC
    J Bacteriol; 2014 Sep; 196(18):3351-9. PubMed ID: 25022851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional synergism of pyoverdine and the S-type pyocins of
    Chen W; Jin F
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1562-1577. PubMed ID: 37154323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Appearance of various pyocin types and subtypes of Pseudomonas aeruginosa in the same patient].
    Vlajinac H
    Vojnosanit Pregl; 1978; 35(4):269-72. PubMed ID: 100965
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines.
    Abdi-Ali A; Worobec EA; Deezagi A; Malekzadeh F
    Can J Microbiol; 2004 May; 50(5):375-81. PubMed ID: 15213746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotyping and pyocin typing of Pseudomonas aeruginosa in a study of intrahospital infections].
    Tomanović B; Joković B; Tatić M; Mirović V; Nanusević O
    Vojnosanit Pregl; 1991; 48(1):31-3. PubMed ID: 1905081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outer membrane translocation of pyocins via the copper regulated TonB-dependent transporter CrtA.
    Premsuriya J; Mosbahi K; Atanaskovic I; Kleanthous C; Walker D
    Biochem J; 2023 Jul; 480(14):1035-1049. PubMed ID: 37399084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.